(212) 292-4573 tmcinnis@mcinnis-law.com

False Claims

False Claims Act

The False Claims Act is found at Title 31, United States Code, Sections 3729-3733. It was originally enacted in 1863 and was intended at the time to address “massive” and “rampant” fraud against the Government arising from Civil War defense contracts and transactions. The False Claims Act is sometimes called the “Lincoln Law” because it was signed into law by President Abraham Lincoln. Due to social, historical and economic changes, the frequency in which the Act has been invoked has risen and fallen over time, and the kinds of commercial activities to which it has been applied have varied, as well. From its inception until the 1990s, the False Claims Act was used mainly in defense contracting. Since then, the majority of cases have been in health care. But the False Claims Act can cover any type of fraud against the Government (other than tax fraud; there is a separate law for that). Senator Chuck Grassley (R-Iowa), former Chairman of the Senate Finance Committee, and sponsor of the 1986 Amendment and subsequent amendments to the Act, has called the False Claims Act “the most powerful tool” in the Government’s arsenal for fighting fraud against the American taxpayers. The U.S Treasury had recovered $35 billion under the Act since the 1986 amendments.

false-clains-act-

The False Claims Act is designed so that either the Government or a private party (known as a relator) or both jointly, may pursue civil actions on behalf of the United States for violations of the Act’s liability provisions. In a small number of cases the Government brings a False Claims Act lawsuit on its own. More often, the relator starts the case and the Government joins it so they end up being co-plaintiffs in the lawsuit. Occasionally, the Government declines to pursue the matter in whole or in part and the relator still goes forward on those “non-intervened” claims on his or her own. When a relator starts the False Claims Act suit, it is known as a “qui tam” action, and the relator gets to share in the ultimate recovery as an incentive for coming forward with his or her information. The typical range for the relator’s share when the Government intervenes in the case is between 15% and 25%. When the Government does not intervene it is between 25% and 30%. In a small number of cases the percentages can go down, but for most successful cases they are in the listed ranges.

A lot of people wonder why so many of the reported qui tam whistleblower cases involve fraud against the Medicare, Medicaid and other government healthcare insurance programs. Not wanting to sound cynical, but it’s similar to what Willie Sutton answered when asked why he robbed banks (“Because that’s where the money is.”), explains Healthcare Fraud Attorney McInnis. Healthcare is one of the biggest categories of government expenditures, so it’s only natural that it would be subject to large amounts of program fraud. While healthcare false claims schemes may take many forms (billing for services never rendered, upcoding diagnoses and procedures, filing duplicate claims, failing to comply with CMS regulations, and so on) and occur at different types of healthcare providers (hospitals, doctor practice groups, pharmaceutical companies and medical device manufacturers), the one thing they all have in common is that some person or some organization submits an invoice or other type of claim to the Government asking to get paid for providing a service or product when the claimant (or people involved in the transaction) knows the claimant is not entitled to receive the requested amount. Thus, in order to get paid from the government healthcare programs, someone has to misrepresent, lie about or cover up important facts which render the claims for reimbursement as false or fraudulent. Filing a qui tam whistleblower suit under the federal or states false claims act is one way to alert the government about such false and fraudulent healthcare billing activity, and in many cases, to help recover money on behalf of the American taxpayers.

"Tim McInnis is an amazing attorney. He is intelligent, thorough, ethical, kind and he works very strategically in order to insure the best outcome for his clients. I would trust him with my life. He is not only an excellent attorney, but he is a compassionate person."
Denise A. Romano, January 2004

"Tim McInnis is a superb lawyer for whistleblowers. As both a relator and a lawyer I worked with for more than three and a

On October 14, 2020, medical device maker Merit Medical Systems Inc. (MMSI), of South Jordan, Utah, agreed to pay $18 million to settle allegations the company helped submit false claims to the federal Medicare and TRICARE programs and numerous state Medicaid programs by giving kickbacks to physicians and hospitals to induce the purchase and use of MMSI’s durable medical equipment devices and products. NYC attorney Timothy J. McInnis was a member of the legal team that successfully represented the whistleblower in the case, Charles J. (“CJ”) Wolf, M.D., who was the former Chief Compliance Officer of MMSI.

 

According to Dr. Wolf’s complaint and the government’s settlement agreement, for over six years MMSI paid kickbacks to physicians, medical practices, and hospitals. The payments were made indirectly under the guise of free advertising assistance, practice development, practice support, and so-called “educational” grants. All of this was intended to induce the healthcare providers to purchase and use MMSI’s products, including EmboSphere devices, which are used for uterine fibroid embolization procedures, and QuadraSphere devices, which are used for other types of embolization procedures. Among other things, MMSI used local advertising campaigns to steer patients to healthcare providers as a reward for past sales and to increase future purchases of MMSI products. Dr. Wolf and the government further alleged that MMSI disregarded numerous internal warnings, including from Dr. Wolf, that MMSI’s sales practices potentially violated the healthcare Anti-Kickback Statute (AKS).

 

The lawsuit was filed in the federal court in District of New Jersey, where attorney McInnis formerly served as an Assistant U.S. Attorney. The case is captioned United States ex rel. Wolf v. Merit Medical Systems, Inc., No. 2:16-cv-01855-CCC-MF (D.N.J.). Of the $18 million MMSI is paying to settle the case, $15.21 million will be go to the U.S. Treasury, and the remaining $2.79 million will go to the approximately 30 individual states that also joined the lawsuit.

half years and his counsel and perseverance were always spot on. His work was critical to a successful settlement of the case."
Stephen B. Diamond, Esq., August, 2016

"Tim McInnis Law represented my case with the up most professionalism. He communicated with me at every turn of the case ensuring I understood the process as well what was to come next. His patience, comprehension of Qui Tam Law and persistence in getting me the highest amount possible out of the case is unmatched. I wouldn't hesitate to recommend his law firm for a minute."
Don A. Briscoe, September 2016

"Tim McInnis Law represented my case with the up most professionalism. He communicated with me at every turn of the case ensuring I understood the process as well what was to come next. His patience, comprehension of Qui Tam Law and persistence in getting me the highest amount possible out of the case is unmatched. I wouldn't hesitate to recommend his law firm for a minute."
Don A. Briscoe, September 2016

Call us anytime 212-292-4573